healthcare technology

Philips beat Q1 earnings expectations with 27-cent EPS versus 23-cent consensus, driven by 6% order growth and strong operational leverage, though revenue missed guidance slightly.

Volaris Group acquires Interplayers, a Brazilian healthcare tech platform serving 70,000+ pharmacies, clinics, and labs, strengthening its Latin America presence.

Middle East and Africa CGM market projected to reach USD 855.30 million by 2034 from USD 320.44 million in 2025, growing at 11.53% CAGR.

Enlitic completes full integration with Sectra, giving healthcare customers direct access to AI-powered imaging tools within existing systems.

Royal Philips secured FDA 510(k) clearance for its Rembra platform, enabling faster CT imaging and radiation therapy planning with capacity for 270 daily exams.

U.S. cardiovascular devices market projected to nearly double to $41.29B by 2032, driven by aging demographics and AI-powered tools.

CareCloud reaffirms guidance after closing $50M credit facility and redeeming all Series B Preferred Stock, capping a decade of transformation from $23M to $130M revenue.

Global allergy diagnostic market projected to reach $10.77B by 2030 from $6.80B in 2025, driven by technological advances and rising allergies.

Global robotic pharmacy market expands from $214M (2025) to $396M (2032) at 9.18% CAGR, driven by medication safety automation and clinical workforce transformation.

IQSTEL ($IQST) partners to enter digital health market, leveraging access to 600+ operators and 2.3B users. Product launch planned for May 2026.

Phreesia stock crashed nearly 50% in Q1 2026 on guidance cuts, but 16% revenue growth, sustained profitability, and 200% free cash flow surge suggest potential rebound.

Philips appoints Chief Medical Officer Dr. Carla Goulart Peron to MDIC board, strengthening industry influence over FDA medical device regulatory standards.

Marpai secures three-year marketing deal with major healthcare provider to expand MarpaiRx PBM services through affiliate network targeting self-insured employers.

Global surgical stapling devices market valued at $5.47B in 2025, projected to reach $10.14B by 2035, growing 7.2% annually driven by minimally invasive procedures and obesity.

Three smaller AI companies—Weave, Evolv, and Pagaya—demonstrate strong revenue growth solving specific problems in healthcare, security, and lending, offering growth investors AI exposure beyond mega-cap leaders.

Aclarion CEO to present NOCISCAN platform at LSI USA 2026 investor conference, advancing AI-powered diagnostic technology for chronic low back pain identification.

Philips launches cloud-based digital pathology platform powered by AWS, enabling healthcare organizations to scale diagnostic workflows without on-premise infrastructure.

Auddia signs non-binding LOI with NYSE-listed medical REIT to deploy LT350 solar-integrated AI micro-datacenter canopy at Dallas-Fort Worth hospital.

Global molecular diagnostics market projected to reach $33.51B by 2031 at 10.43% CAGR, driven by precision medicine adoption and genomic testing advances.

Marpai secures access to 1.5 million covered lives via marketing agreement, providing MarpaiRx with major distribution channel and substantial new revenue growth opportunities in pharmacy benefits.